<DOC>
	<DOCNO>NCT01350596</DOCNO>
	<brief_summary>An open label , randomize , 2x2 crossover , single dose , phase 4 study determine pharmaceutical bioequivalence ibuprofen 50mg/ml ( laboratórios pfizer ltda ) oral suspension versus alivium ® 50mg/ml ( mantecorp indústria química e farmacêutica ltda . ) Oral suspension , healthy fasting volunteer .</brief_summary>
	<brief_title>A Bioequivalence Study Of Ibuprofen 50mg/ml ( laboratórios Pfizer Ltda ) In The Oral Suspension Form .</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy 18 55 year old male female subject ( Healthy define absence clinically relevant abnormality identify detailed medical history , complete physical examination , include blood pressure heart rate measurement , 12lead ECG clinical laboratory test ) . Volunteers ' BMI Body Mass Index must range 18.5 24.9 ( Dietary Guidelines Americans ) , however , range 15 % upper limit ( 18.5 28.63 ) total body weight &gt; 50kg . Signed date Informed Consent Form subject legally acceptable representative . If subject and/or legally acceptable representative unable read Informed Consent Form , impartial witness may sign . Subjects willing able comply schedule visit , treatment plan , laboratory test study procedure . Evidence history hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurological , allergic clinically significant disease ( include drug allergy , except seasonal allergy , asymptomatic , untreated time dose ) . Any condition may possibly affect drug absorption ( e.g . gastrectomy ) . Volunteer present drug abuse history [ patient make use marijuana hashish exclude use drug less three month medical appointment , volunteer use drug cocaine , phencyclidine ( PCP ) , crack heroin , exclude use less one year medical appointment ] . A positive drug test urine ( Methamphetamine , Opiate , Morphine , Marijuana , Cannabis , Amphetamine , Cocaine , Benzodiazepine , Benzoylecgonine ) positive test alcohol admission period 1 2 . History regular alcohol consumption exceed 7 drinks/week woman 14 drinks/week men ( 1 serve = 150 mL wine 360 mL beer 45 mL concentrate liquor ) within 6 month selection . If volunteer participate experimental study take experimental drug within 6 month prior baseline ( ANVISA : RDC Resolution No . 34 , June 3 , 2008 ) . 12lead ECG demonstrate QTc &gt; 450 msec screen visit . If QTc exceed 450 msec , ECG repeat twice average three QTc value use determine patient 's eligibility . Pregnant breastfeed woman , woman childbearing potential unwilling unable use nonhormonal acceptable contraception method , describe protocol , least 14 day first dose study medication . Use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) first dose study medication . Phytotherapic medicine phytotherapic supplement discontinue 28 day first dose study medication . With one exception , acetaminophen/paracetamol use dose 1 g/day . The limited use nonprescription medication consider affect patient 's safety general study result may allow case case basis sponsor 's approval . Blood donation approximately 500 mL within 3 month dosage . Known hypersensitivity Ibuprofen chemically related compound ; Volunteers acetylsalicylic acid , iodate Nonsteroidal antiinflammatory drug induce asthma , rhinitis , urticaria , nasal polyp , angioedema , bronchospasm symptom allergic anaphylactic reaction . Sensitivity History heparin heparininduced thrombocytopenia . Unwillingness inability comply Lifestyle Guidelines describe protocol . Other psychiatric severe acute clinically chronic condition laboratory abnormality may increase risk associate participation study administration investigational product , may interfere interpretation study result , opinion investigator , would make patient inadequate enter study . A positive beta HCG test woman . If volunteer present condition prevents participation study , accord opinion investigator . Volunteer gastroduodenal ulcer , previous active gastrointestinal bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Bioequivalence Study</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Alivium</keyword>
</DOC>